AAVXF
Price
$7.28
Change
+$1.47 (+25.30%)
Updated
Jun 11 closing price
Capitalization
513.87M
CNSP
Price
$0.92
Change
-$0.02 (-2.13%)
Updated
Jul 3 closing price
Capitalization
5.02M
Interact to see
Advertisement

AAVXF vs CNSP

Header iconAAVXF vs CNSP Comparison
Open Charts AAVXF vs CNSPBanner chart's image
Abivax SA
Price$7.28
Change+$1.47 (+25.30%)
Volume$300
Capitalization513.87M
CNS Pharmaceuticals
Price$0.92
Change-$0.02 (-2.13%)
Volume$71.08K
Capitalization5.02M
AAVXF vs CNSP Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. CNSP commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and CNSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AAVXF: $7.28 vs. CNSP: $0.92)
Brand notoriety: AAVXF and CNSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 177% vs. CNSP: 3%
Market capitalization -- AAVXF: $513.87M vs. CNSP: $5.02M
AAVXF [@Biotechnology] is valued at $513.87M. CNSP’s [@Biotechnology] market capitalization is $5.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileCNSP’s FA Score has 1 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • CNSP’s FA Score: 1 green, 4 red.
According to our system of comparison, CNSP is a better buy in the long-term than AAVXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 3 TA indicator(s) are bullish while CNSP’s TA Score has 4 bullish TA indicator(s).

  • AAVXF’s TA Score: 3 bullish, 2 bearish.
  • CNSP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AAVXF and CNSP are a good buy in the short-term.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while CNSP (@Biotechnology) price change was +9.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CNSP is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($514M) has a higher market cap than CNSP($5.03M). AAVXF YTD gains are higher at: -34.118 vs. CNSP (-84.718). CNSP has higher annual earnings (EBITDA): -15.6M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. CNSP (13M). CNSP has less debt than AAVXF: CNSP (211K) vs AAVXF (92.6M). AAVXF (0) and CNSP (0) have equivalent revenues.
AAVXFCNSPAAVXF / CNSP
Capitalization514M5.03M10,229%
EBITDA-170.04M-15.6M1,090%
Gain YTD-34.118-84.71840%
P/E RatioN/A0.00-
Revenue00-
Total Cash104M13M800%
Total Debt92.6M211K43,886%
FUNDAMENTALS RATINGS
AAVXF: Fundamental Ratings
AAVXF
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFCNSP
RSI
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
24%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TISCX28.68N/A
N/A
Nuveen Large Cap Responsible Eq R6
FHETX16.59N/A
N/A
Fidelity Advisor Real Estate M
VSQRX17.55N/A
N/A
Invesco MSCI World SRI Index R
BMSTX14.81N/A
N/A
MFS Blended Research Mid Cap Eq R3
ANVRX10.22N/A
N/A
American Century Non-US Intrs Val R

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
+0.58%
CNSP - AAVXF
34%
Loosely correlated
-2.12%
ACHV - AAVXF
28%
Poorly correlated
-3.54%
RENB - AAVXF
26%
Poorly correlated
+3.44%
More

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with VIR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-2.12%
VIR - CNSP
36%
Loosely correlated
-0.37%
AAVXF - CNSP
34%
Loosely correlated
N/A
PTGX - CNSP
30%
Poorly correlated
+0.71%
MGNX - CNSP
27%
Poorly correlated
+5.80%
NRIX - CNSP
26%
Poorly correlated
+2.33%
More